{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:44:44Z","timestamp":1789343084806,"version":"build-2803163510"},"reference-count":236,"publisher":"Elsevier","isbn-type":[{"value":"9780443343735","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.acc.2024.10.002","type":"book-chapter","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:51:06Z","timestamp":1730983866000},"page":"87-122","source":"Crossref","is-referenced-by-count":4,"title":["Lupus nephritis: Biomarkers"],"prefix":"10.1016","author":[{"given":"Chrisanna","family":"Dobrowolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Min","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Kharouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Parnizari","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Wither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Whitall","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arenn","family":"Jauhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acc.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib4","first-page":"753","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arth\u00a0Rheumat"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005792-199905000-00002","article-title":"Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center","volume":"78","author":"Huong","year":"1999","journal-title":"Med. (Baltim.)"},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2011.04.032","article-title":"Epidemiology and management of refractory lupus nephritis","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmunity Rev."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MAJ.0b013e3181907b3d","article-title":"Lupus nephritis","volume":"337","author":"Singh","year":"2009","journal-title":"Am. J. Med. Sci."},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1191\/096120398678920479","article-title":"The clinical features and prognosis of male lupus in Taiwan","volume":"7","author":"Chang","year":"1998","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1191\/0961203305lu2245oa","article-title":"Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients","volume":"14","author":"Garcia","year":"2005","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/0961203311403640","article-title":"Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison","volume":"20","author":"Stefanidou","year":"2011","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib11","first-page":"113","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients","volume":"72","author":"Cervera","year":"1993","journal-title":"Eur. Working Party Systemic Lupus Erythematosus. Med. (Baltim.)"},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Med. (Baltim. )"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","article-title":"Predictors of survival in systemic lupus erythematosus","volume":"85","author":"Kasitanon","year":"2006","journal-title":"Med. (Baltim.)"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib15","first-page":"357","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the georgia lupus registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arth\u00a0Rheumatol."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib16","first-page":"369","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the michigan lupus epidemiology and surveillance program: incidence and prevalence of SLE in Southeastern Michigan","volume":"66","author":"Somers","year":"2014","journal-title":"Arth\u00a0Rheumatol."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/art.40192","article-title":"The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan Lupus Surveillance Program","volume":"69","author":"Izmirly","year":"2017","journal-title":"Arthritis & Rheumatol."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/ndt\/gfg345","article-title":"Prognosis in proliferative lupus nephritis: the role of socio-economic status and race\/ethnicity","volume":"18","author":"Barr","year":"2003","journal-title":"Nephrol.\u00a0Dial.\u00a0Transpl.\u00a0Off. Publ. Eur. Dialysis Transpl. Assoc. - Eur. Ren. Assoc."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of the Joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib20","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/art.34472","article-title":"Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary population.","volume":"64","author":"Hiraki","year":"2012","journal-title":"Arth.\u00a0Rheumat."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/0961203312443421","article-title":"Lupus nephritis is more severe in children and adolescents than in older adults","volume":"21","author":"Sato","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/096120339900800609","article-title":"Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI","volume":"8","author":"Formiga","year":"1999","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0002-9343(02)01118-X","article-title":"Demographic differences in the development of lupus nephritis: a retrospective analysis","volume":"112","author":"Seligman","year":"2002","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"issue":"272","key":"10.1016\/bs.acc.2024.10.002_bib25","first-page":"1125","article-title":"Kidney biopsy in SLE. I. A clinical-morphologic evaluation","volume":"73","author":"Gladman","year":"1989","journal-title":"Q. J. Med."},{"key":"10.1016\/bs.acc.2024.10.002_bib26","volume":"Vol. 2","author":"Hochberg","year":"2019"},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib27","first-page":"2154","article-title":"Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus: SMR and life expectancy of patients with lupus renal disease","volume":"65","author":"Mok","year":"2013","journal-title":"Arth\u00a0Rheumat"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib28","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/rheumatology\/keab775","article-title":"History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis","volume":"61","author":"Fava","year":"2022","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1191\/0961203305lu2059oa","article-title":"Lupus nephritis flares","volume":"14","author":"Sidiropoulos","year":"2005","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib30","first-page":"995","article-title":"Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies","volume":"46","author":"Illei","year":"2002","journal-title":"Arth\u00a0Rheumat"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ki.1996.528","article-title":"Nephritic flares are predictors of bad long-term renal outcome in lupus nephritis","volume":"50","author":"Moroni","year":"1996","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203308090029","article-title":"Current treatment of lupus nephritis","volume":"17","author":"Houssiau","year":"2008","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib34","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1097\/01.ASN.0000140218.77174.0A","article-title":"Management of lupus nephritis: an update","volume":"15","author":"Houssiau","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib35","first-page":"3934","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial: early response to treatment predicts good outcome in lupus nephritis","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arth\u00a0Rheumat"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int."},{"issue":"Suppl 5","key":"10.1016\/bs.acc.2024.10.002_bib37","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatol. (Oxf.)"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3899\/jrheum.200161","article-title":"Factors associated with rapid progression to endstage kidney disease in lupus nephritis","volume":"48","author":"Tselios","year":"2021","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/sdi.12122","article-title":"Improving outcomes in patients with lupus and end-stage renal disease","volume":"26","author":"Inda-Filho","year":"2013","journal-title":"Semin. Dial."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib40","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol.\u00a0Dialysis Transplant."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology."},{"key":"10.1016\/bs.acc.2024.10.002_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/IJWH.S28034","article-title":"Understanding lupus nephritis: diagnosis, management, and treatment options","author":"Mok","year":"2012","journal-title":"IJWH"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib43","first-page":"1577","article-title":"Serious infections among adult medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis: serious infections in sle and lupus nephritis","volume":"67","author":"Feldman","year":"2015","journal-title":"Arth\u00a0Rheumatol."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib44","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical\u2013histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann. Rheumatic Dis."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib45","first-page":"1432","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and bayesian meta-analysis: ESRD risk in lupus nephritis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arth\u00a0Rheumatol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0049-0172(97)80033-9","article-title":"Outcome of renal transplantation in systemic lupus erythematosus","volume":"27","author":"Stone","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.semarthrit.2016.09.008","article-title":"The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: systematic literature review and analysis of the Toronto lupus cohort","volume":"46","author":"Yap","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/bs.acc.2024.10.002_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew475","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study","author":"Hermansen","year":"2017","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib49","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/0961203319847275","article-title":"Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort","volume":"28","author":"Reppe Moe","year":"2019","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","article-title":"Leveraging heterogeneity in systemic lupus erythematosus for new therapies","volume":"27","author":"Allen","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/bs.acc.2024.10.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100291","article-title":"Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study","volume":"20","author":"Guthridge","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2015.33","article-title":"Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mohan","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib53","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2024.10.002_bib54","series-title":"Lupus Nephritis. Fundamentals of Renal Pathology","first-page":"89","author":"Fogo","year":"2014"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-024-03311-y","article-title":"Integrative analysis of single-cell and bulk transcriptome data reveal the significant role of macrophages in lupus nephritis","volume":"26","author":"Wei","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/bs.acc.2024.10.002_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2018.05.041","article-title":"The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry","volume":"668","author":"Goulielmos","year":"2018","journal-title":"Gene"},{"key":"10.1016\/bs.acc.2024.10.002_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2016.09.012","article-title":"Genetics of human lupus nephritis","volume":"185","author":"Iwamoto","year":"2017","journal-title":"Clin. Immunol."},{"issue":"1-3","key":"10.1016\/bs.acc.2024.10.002_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12026-014-8523-2","article-title":"Toll-like receptors and B cells: functions and mechanisms","volume":"59","author":"Buchta","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/bs.acc.2024.10.002_bib59","doi-asserted-by":"crossref","DOI":"10.12703\/P5-40","article-title":"B lymphocyte antigen receptor signaling: initiation, amplification, and regulation","volume":"5","author":"Packard","year":"2013","journal-title":"F1000 Prime Rep."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2008.07.047","article-title":"Altered B cell receptor signaling in human systemic lupus erythematosus","volume":"8","author":"Jenks","year":"2009","journal-title":"Autoimmunity Rev."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41435-021-00142-8","article-title":"Variants in BANK1 are associated with lupus nephritis of European ancestry","volume":"22","author":"Bolin","year":"2021","journal-title":"Genes. Immun."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0960-9822(00)00024-5","article-title":"Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn","volume":"11","author":"Yu","year":"2001","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cmi.2012.64","article-title":"B-cell-targeted therapies in systemic lupus erythematosus","volume":"10","author":"Chan","year":"2013","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10875-006-9051-1","article-title":"Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss","volume":"27","author":"Culton","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib66","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupuserythematosus induced by anti-tumour necrosis factor alpha therapy: a Frenchnational survey","volume":"7","author":"The Club Rhumatismes et I","year":"2005","journal-title":"Arth. Res. Ther."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib67","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc. Natl Acad. Sci. U S A"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1399-0039.1999.530602.x","article-title":"Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus: TNFR2 polymorphism in SLE","volume":"53","author":"Komata","year":"1999","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.gene.6363700","article-title":"New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus","volume":"1","author":"Tsuchiya","year":"2000","journal-title":"Genes. Immun."},{"key":"10.1016\/bs.acc.2024.10.002_bib70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in systemic lupus erythematosus","volume":"43","author":"Su\u00e1rez-Fueyo","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780190201","article-title":"Histocompatibility antigens in systemic lupus erythematosus","volume":"19","author":"Goldberg","year":"1976","journal-title":"Arth.\u00a0Rheumat."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib72","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.ejhg.5201827","article-title":"Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE","volume":"15","author":"Graham","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Erythematosus","year":"2008","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084450","article-title":"Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis","volume":"8","author":"Bolin","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib75","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2013050446","article-title":"Lupus nephritis susceptibility loci in women with systemic lupus erythematosus","volume":"25","author":"Chung","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001311","article-title":"Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes","volume":"7","author":"Taylor","year":"2011","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1756-185X.12528","article-title":"Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis","volume":"18","author":"Niu","year":"2015","journal-title":"Int. J. Rheumatic Dis."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib78","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajhg.2012.02.023","article-title":"Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study","volume":"90","author":"Lessard Christopher","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.gene.6364252","article-title":"The R620W C\/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1","volume":"6","author":"Reddy","year":"2005","journal-title":"Genes. Immun."},{"key":"10.1016\/bs.acc.2024.10.002_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866549","article-title":"T helper 2-associated immunity in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Ko","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib81","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semnephrol.2015.08.002","article-title":"Genetics of lupus nephritis: clinical implications","volume":"35","author":"Munroe","year":"2015","journal-title":"Semin. Nephrol."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib82","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.3390\/ijms16047917","article-title":"Pathogenesis of renal disease in systemic lupus erythematosus\u2014the role of autoantibodies and lymphocytes subset abnormalities","volume":"16","author":"Yap","year":"2015","journal-title":"IJMS"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunological Rev."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0256-4947.75775","article-title":"OX40\/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis","volume":"31","author":"Farres","year":"2011","journal-title":"Ann. Saudi Med."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib85","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4049\/jimmunol.171.3.1564","article-title":"Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice","volume":"171","author":"Jacob","year":"2003","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib86","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/ard.2011.154104","article-title":"Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus","volume":"70","author":"Sanchez","year":"2011","journal-title":"Ann. Rheumatic Dis."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000084","article-title":"Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus","volume":"4","author":"Taylor","year":"2008","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib88","first-page":"854","article-title":"Association of interleukin-10 gene -592 A\/C polymorphism with the clinical and pathological diversity of lupus nephritis","volume":"23","author":"Zhu","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib89","first-page":"603","article-title":"IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus","volume":"27","author":"Hermann","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib90","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/rheumatology\/kei184","article-title":"Interleukin-10 gene polymorphisms are associated with the SLICC\/ACR Damage Index in systemic lupus erythematosus","volume":"45","author":"Sung","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/bs.acc.2024.10.002_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13578-015-0056-4","article-title":"NF-\u03baB in inflammation and renal diseases","volume":"5","author":"Zhang","year":"2015","journal-title":"Cell Biosci."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcp.2009.02.009","article-title":"ABINs: A20 binding inhibitors of NF-\u03baB and apoptosis signaling","volume":"78","author":"Verstrepen","year":"2009","journal-title":"Biochem.\u00a0Pharmacol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib93","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2009.31","article-title":"Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations","volume":"10","author":"Bates","year":"2009","journal-title":"Genes. Immun."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib94","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1681\/ASN.2013020148","article-title":"ABIN1 dysfunction as a genetic basis for lupus nephritis","volume":"24","author":"Caster","year":"2013","journal-title":"J. Am. Soc. Nephrology"},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib95","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/ckj\/sfac130","article-title":"Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis","volume":"15","author":"Zhang","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib96","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-016-1034-x","article-title":"JAK3-STAT pathway blocking benefits in experimental lupus nephritis","volume":"18","author":"Ripoll","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib97","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib98","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1002\/humu.20997","article-title":"Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B","volume":"30","author":"Breunis","year":"2009","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib99","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1288","article-title":"Loss of function of a lupus-associated Fc\u03b3RIIb polymorphism through exclusion from lipid rafts","volume":"11","author":"Floto","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib100","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1046\/j.1523-1755.2003.00873.x","article-title":"The Fc\u03b3RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis","volume":"63","author":"Karassa","year":"2003","journal-title":"Kidney Int."},{"issue":"1-3","key":"10.1016\/bs.acc.2024.10.002_bib101","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","article-title":"TLR7 and TLR9 in SLE: when sensing self goes wrong","volume":"53","author":"Celhar","year":"2012","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","article-title":"Toll-like receptors in lupus nephritis","volume":"25","author":"Devarapu","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/bs.acc.2024.10.002_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/780436","article-title":"Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus","volume":"2012","author":"Cham","year":"2012","journal-title":"Clin. Develop. Immunol."},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib104","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1440-1797.2010.01327.x","article-title":"Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population: IRF5 polymorphisms in Chinese LN patients","volume":"15","author":"Qin","year":"2010","journal-title":"Nephrology"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib105","first-page":"397","article-title":"Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population","volume":"28","author":"Zhou","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib106","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1038\/s41467-021-24609-4","article-title":"Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease","volume":"12","author":"Ban","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.acc.2024.10.002_bib107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2018.00052","article-title":"CD11b activity modulates pathogenesis of lupus nephritis","volume":"5","author":"Khan","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib108","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/gene.2009.35","article-title":"Fc\u03b3 receptors: structure, function and role as genetic risk factors in SLE","volume":"10","author":"Li","year":"2009","journal-title":"Genes. Immun."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib109","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/08916930701763710","article-title":"Fc receptor genes and the systemic lupus erythematosus diathesis","volume":"40","author":"Brown","year":"2007","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ng2046","article-title":"FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity","volume":"39","author":"Fanciulli","year":"2007","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/bs.acc.2024.10.002_bib111","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.108.771170","article-title":"Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury","volume":"120","author":"Mayadas","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","article-title":"The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved","volume":"36","author":"Rekvig","year":"2014","journal-title":"Semin. Immunopathol."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib113","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/art.38749","article-title":"Brief report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern han Chinese by shared-gene analysis with IgA nephropathy: MTMR3 in lupus nephritis","volume":"66","author":"Zhou","year":"2014","journal-title":"Arth.\u00a0Rheumatol."},{"issue":"21","key":"10.1016\/bs.acc.2024.10.002_bib114","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"19","key":"10.1016\/bs.acc.2024.10.002_bib115","doi-asserted-by":"crossref","first-page":"17303","DOI":"10.1074\/jbc.M110.182998","article-title":"A systemic lupus erythematosus-associated R77H substitution in the CD11b Chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis","volume":"286","author":"MacPherson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2024.10.002_bib116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","article-title":"Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"185","author":"Mistry","year":"2017","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib117","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00296-009-1199-6","article-title":"DNase1 activity in systemic lupus erythematosus patients with and without nephropathy","volume":"30","author":"Martinez-Valle","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib118","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0961203313498801","article-title":"Q222R polymorphism in DNAse I gene is a risk factor for nephritis in South Indian SLE patients","volume":"22","author":"Panneer","year":"2013","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.autrev.2010.02.003","article-title":"Pathways: strategies for susceptibility genes in SLE","volume":"9","author":"Kelley","year":"2010","journal-title":"Autoimmunity Rev."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"CJASN"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib121","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1: APOL1 in lupus nephritis ESRD","volume":"66","author":"Freedman","year":"2014","journal-title":"Arth.\u00a0Rheumatol."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib122","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2011.82","article-title":"Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis","volume":"13","author":"Lin","year":"2012","journal-title":"Genes. Immun."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib123","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gpb.2013.05.003","article-title":"Biomarker profiling for lupus nephritis","volume":"11","author":"Li","year":"2013","journal-title":"Genom. Proteom. Bioinformatics."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11926-013-0369-4","article-title":"Genetics and epigenetics of systemic lupus erythematosus","volume":"15","author":"Costa-Reis","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/bs.acc.2024.10.002_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.925416","article-title":"Lupus nephritis: the regulatory interplay between epigenetic and MicroRNAs","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2302\/kjm.60.10","article-title":"Epigenetics and autoimmunity, with special emphasis on methylation","volume":"60","author":"Renaudineau","year":"2011","journal-title":"Keio J. Med."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2010.05831.x","article-title":"Epigenetics in lupus: epigenetics in lupus","volume":"1217","author":"Zouali","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.molmed.2011.07.005","article-title":"Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases","volume":"17","author":"Hedrich","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib129","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000183","article-title":"Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses","volume":"3","author":"Mok","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/bs.acc.2024.10.002_bib130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2015.05.003","article-title":"Renal involvement in lupus is characterized by unique DNA methylation changes in na\u00efve CD4+ T cells","volume":"61","author":"Coit","year":"2015","journal-title":"J. Autoimmunity"},{"issue":"22","key":"10.1016\/bs.acc.2024.10.002_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143654","article-title":"A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients","volume":"5","author":"Coit","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/bs.acc.2024.10.002_bib132","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/fimmu.2019.02026","article-title":"Transcriptomic and epigenetic alterations in dendritic cells correspond with chronic kidney disease in lupus nephritis","volume":"10","author":"Wardowska","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2024.10.002_bib133","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fimmu.2018.01473","article-title":"B cell-related circulating MicroRNAs with the potential value of biomarkers in the differential diagnosis, and distinguishment between the disease activity and lupus nephritis for systemic lupus erythematosus","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2024.10.002_bib134","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3389\/fimmu.2020.01732","article-title":"B cell subsets and cellular signatures and disease relapse in lupus nephritis","volume":"11","author":"Yap","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-019-2044-2","article-title":"LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration","volume":"21","author":"Luan","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/bs.acc.2024.10.002_bib136","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3389\/fimmu.2019.02229","article-title":"MiRNA regulation of MIF in SLE and attenuation of murine lupus nephritis with miR-654","volume":"10","author":"Tu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2024.10.002_bib137","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fimmu.2019.00158","article-title":"miR-152 attenuates the severity of lupus nephritis through the downregulation of macrophage migration inhibitory factor (MIF)-induced expression of COL1A1","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00296-008-0758-6","article-title":"Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients","volume":"29","author":"Dai","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib139","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1797.2012.01573.x","article-title":"Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis: miRNA in lupus nephritis","volume":"17","author":"Lu","year":"2012","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010344","article-title":"Identification of unique MicroRNA signature associated with lupus nephritis","volume":"5","author":"Te","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib141","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/0961203312451334","article-title":"Urinary sediment ICAM-1 level in lupus nephritis","volume":"21","author":"Guan","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib142","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.22646","article-title":"Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus","volume":"56","author":"Dieker","year":"2007","journal-title":"Arth.\u00a0Rheumat."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib143","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib144","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/03009740902895750","article-title":"Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL\/lpr mice","volume":"38","author":"Hu","year":"2009","journal-title":"Scand. J. Rheumatol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/CS20171410","article-title":"Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis","volume":"132","author":"Olivares","year":"2018","journal-title":"Clin. Sci."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.144","article-title":"Upregulation of Fc\u03b3RIIB by resveratrol via NF-\u03baB activation reduces B-cell numbers and ameliorates lupus","volume":"49","author":"Jhou","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib147","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib148","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3899\/jrheum.130005","article-title":"Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment","volume":"41","author":"Touma","year":"2014","journal-title":"J. Rheumatol."},{"issue":"4S","key":"10.1016\/bs.acc.2024.10.002_bib149","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1159\/000531333","article-title":"Comparison of urinary protein\/creatinine ratio as an alternative to 24-h proteinuria in lupus nephritis: TUNARI study","volume":"147","author":"Gutierrez-Peredo","year":"2023","journal-title":"Nephron"},{"key":"10.1016\/bs.acc.2024.10.002_bib151","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13075-015-0808-x","article-title":"Utility of untimed single urine protein\/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus","volume":"17","author":"Medina-Rosas","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib152","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2024.10.002_bib153","article-title":"KDIGO 2024 clinical practice guideline for the management of lupus nephritis","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2024.10.002_bib154","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaut.2016.06.006","article-title":"Lupus nephritis: when and how often to biopsy and what does it mean?","volume":"74","author":"Moroni","year":"2016","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rdc.2014.04.004","article-title":"The kidney biopsy in lupus nephritis: is it still relevant?","volume":"40","author":"Rovin","year":"2014","journal-title":"Rheum. Dis. Clin. North. Am."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib156","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","article-title":"Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","volume":"97","author":"Malvar","year":"2020","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib157","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/ckj\/sfac150","article-title":"Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment","volume":"15","author":"Lledo-Ibanez","year":"2022","journal-title":"Clin. Kidney J."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib158","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000932","article-title":"Remission of lupus nephritis: the trajectory of histological response in successfully treated patients","volume":"10","author":"Malvar","year":"2023","journal-title":"Lupus Sci. Med."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib159","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5114\/reum.2016.60211","article-title":"Repeat renal biopsy in lupus nephritis - unnecessary harm and risk of complications or important diagnostic tool with clinical consequences?","volume":"54","author":"Haladyj","year":"2016","journal-title":"Reumatologia"},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib161","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","article-title":"A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy","volume":"94","author":"De Rosa","year":"2018","journal-title":"Kidney Int."},{"issue":"suppl_1","key":"10.1016\/bs.acc.2024.10.002_bib162","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/ndt\/gfw300","article-title":"Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise","volume":"32","author":"Birmingham","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib163","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1756-185X.12602","article-title":"Biomarkers in lupus nephritis","volume":"18","author":"Misra","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/bs.acc.2024.10.002_bib164","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/638413","article-title":"Biomarkers for lupus nephritis: a critical appraisal","volume":"2010","author":"Mok","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.ackd.2019.09.001","article-title":"Utilization of biomarkers in lupus nephritis","volume":"26","author":"Caster","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib166","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0961203310385163","article-title":"SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation","volume":"20","author":"Touma","year":"2011","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib167","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7","key":"10.1016\/bs.acc.2024.10.002_bib168","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.ki.5002421","article-title":"Spot urine protein\/creatinine ratios are unreliable estimates of 24h proteinuria in most systemic lupus erythematosus nephritis flares","volume":"72","author":"Birmingham","year":"2007","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib169","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/RHU.0b013e318214bd18","article-title":"Comparison of proteinuria determination by urine dipstick, spot urine protein creatinine index, and urine protein 24\u00a0h in lupus patients","volume":"17","author":"Chotayaporn","year":"2011","journal-title":"J. Clin. Rheumatol."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib170","first-page":"1557","article-title":"Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis","volume":"31","author":"Christopher-Stine","year":"2004","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib171","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ekir.2018.04.010","article-title":"Limited reliability of the spot urine protein\/creatinine ratio in the longitudinal evaluation of patients with lupus nephritis","volume":"3","author":"Shidham","year":"2018","journal-title":"Kidney Int. Rep."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib172","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort","volume":"67","author":"Dall\u2019Era","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib173","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/bs.acc.2024.10.002_bib174","doi-asserted-by":"crossref","first-page":"5312960","DOI":"10.1155\/2017\/5312960","article-title":"Predictors of good long-term renal outcomes in lupus nephritis: results from a single lupus cohort","volume":"2017","author":"Fung","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib175","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib176","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/133.2.233","article-title":"Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications","volume":"133","author":"Seshan","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib177","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib178","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00296-011-1940-9","article-title":"Renal function assessment in patients with systemic lupus erythematosus","volume":"32","author":"Martinez-Martinez","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib179","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1191\/0961203306lu2300oa","article-title":"Estimation of glomerular filtration rate in patients with systemic lupus erythematosus","volume":"15","author":"Leung","year":"2006","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib180","first-page":"99","article-title":"CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus","volume":"33","author":"Martinez-Martinez","year":"2013","journal-title":"Nefrologia"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib181","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2022.02.022","article-title":"Glomerular hematuria and the utility of urine microscopy: a review","volume":"80","author":"Saha","year":"2022","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib182","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0961203316669241","article-title":"Urinary sediment suggests lupus nephritis histology","volume":"26","author":"Martinez-Martinez","year":"2017","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib183","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib184","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3899\/jrheum.140415","article-title":"Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity","volume":"42","author":"Ding","year":"2015","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib185","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0272-6386(95)90488-3","article-title":"Relationship between appearance of urinary red blood cell\/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus","volume":"26","author":"Hebert","year":"1995","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib186","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib187","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arth.\u00a0Rheumatol."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib188","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8","article-title":"Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arth.\u00a0Rheum."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib189","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2215\/CJN.01910213","article-title":"Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis","volume":"8","author":"Olson","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/bs.acc.2024.10.002_bib190","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/40.12.1405","article-title":"An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study","volume":"40","author":"Ravirajan","year":"2001","journal-title":"Rheumatol. (Oxf.)"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib191","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2008.094508","article-title":"Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis","volume":"68","author":"Moroni","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib192","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0961203310379871","article-title":"Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares","volume":"20","author":"Matrat","year":"2011","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib193","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1093\/ndt\/gfs179","article-title":"Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis","volume":"27","author":"Yang","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib194","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib195","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000112","article-title":"Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders","volume":"2","author":"Parikh","year":"2015","journal-title":"Lupus Sci. Med."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib196","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0961203312451202","article-title":"Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis","volume":"21","author":"Yin","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib197","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.03990415","article-title":"Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare","volume":"11","author":"Birmingham","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2024.10.002_bib198","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40364-020-00236-x","article-title":"Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study","volume":"8","author":"Gamez-Nava","year":"2020","journal-title":"Biomark Res."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib199","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1523-1755.2005.00601.x","article-title":"Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus","volume":"68","author":"Rovin","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13075-016-1120-0","article-title":"A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis","volume":"18","author":"Landolt-Marticorena","year":"2016","journal-title":"Arth.\u00a0Res. Ther."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib201","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/art.24751","article-title":"Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity","volume":"60","author":"Hinze","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib202","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis","volume":"49","author":"Rubinstein","year":"2010","journal-title":"Rheumatol. (Oxf.)"},{"key":"10.1016\/bs.acc.2024.10.002_bib203","doi-asserted-by":"crossref","first-page":"2768326","DOI":"10.1155\/2020\/2768326","article-title":"Elevated urinary neutrophil gelatinase-associated lipocalin is a biomarker for lupus nephritis: a systematic review and meta-analysis","volume":"2020","author":"Gao","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib204","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s10875-011-9555-1","article-title":"Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis","volume":"31","author":"El-Shehaby","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00393-016-0184-1","article-title":"Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis","volume":"77","author":"Salem","year":"2018","journal-title":"Z. Rheumatol."},{"issue":"5","key":"10.1016\/bs.acc.2024.10.002_bib206","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar2816","article-title":"Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study","volume":"11","author":"Schwartz","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/0886022X.2020.1853568","article-title":"Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"43","author":"Ma","year":"2021","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib208","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0961203320914372","article-title":"Diagnostic value of urinary monocyte chemoattractant protein-1 in evaluating the activity of lupus nephritis: a meta-analysis","volume":"29","author":"Xia","year":"2020","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib209","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10067-016-3404-9","article-title":"Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263778","article-title":"Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios","volume":"17","author":"Ngamjanyaporn","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib211","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1681\/ASN.2004080658","article-title":"Urine chemokines as biomarkers of human systemic lupus erythematosus activity","volume":"16","author":"Rovin","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/bs.acc.2024.10.002_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.885307","article-title":"Urine ALCAM, PF4 and VCAM-1 surpass conventional metrics in identifying nephritis disease activity in childhood-onset systemic lupus erythematosus","volume":"13","author":"Soliman","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2024.10.002_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.910993","article-title":"Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis","volume":"13","author":"Soliman","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib214","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3912","article-title":"Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis","volume":"14","author":"Singh","year":"2012","journal-title":"Arth.\u00a0Res. Ther."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib215","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/1756-185X.13197","article-title":"Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis","volume":"20","author":"Soliman","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib216","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s41927-020-00162-3","article-title":"Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis","volume":"4","author":"Gasparin","year":"2020","journal-title":"BMC Rheumatol."},{"key":"10.1016\/bs.acc.2024.10.002_bib217","doi-asserted-by":"crossref","first-page":"1044743","DOI":"10.3389\/fimmu.2022.1044743","article-title":"A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM","volume":"13","author":"Lei","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib218","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-020-02209-9","article-title":"Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology","volume":"22","author":"Ding","year":"2020","journal-title":"Arth.\u00a0Res. Ther."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib219","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147334","article-title":"The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses","volume":"132","author":"Chalmers","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/bs.acc.2024.10.002_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240942","article-title":"The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib221","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/0961203314526292","article-title":"Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis","volume":"23","author":"Nozaki","year":"2014","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib222","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/cei.12894","article-title":"Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis","volume":"187","author":"Phatak","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.acc.2024.10.002_bib223","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fimmu.2020.00671","article-title":"Association of urine sCD163 with proliferative lupus nephritis, fibrinoid necrosis, cellular crescents and intrarenal M2 macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/bs.acc.2024.10.002_bib224","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2019121285","article-title":"Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis","volume":"31","author":"Mejia-Vilet","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/bs.acc.2024.10.002_bib225","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10067-020-05343-6","article-title":"Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis","volume":"40","author":"Gupta","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib226","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000747","article-title":"Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis","volume":"10","author":"Akhgar","year":"2023","journal-title":"Lupus Sci. Med."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib227","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-015-0600-y","article-title":"The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers","volume":"17","author":"Kopetschke","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/bs.acc.2024.10.002_bib228","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40620-020-00832-y","article-title":"Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis","volume":"34","author":"Perez-Hernandez","year":"2021","journal-title":"J. Nephrol."},{"key":"10.1016\/bs.acc.2024.10.002_bib229","doi-asserted-by":"crossref","first-page":"1077645","DOI":"10.3389\/fimmu.2023.1077645","article-title":"Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/bs.acc.2024.10.002_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138618","article-title":"Increased urinary exosomal MicroRNAs in patients with systemic lupus erythematosus","volume":"10","author":"Perez-Hernandez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2024.10.002_bib231","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889931","article-title":"Identification and validation of a urinary biomarker panel to accurately diagnose and predict response to therapy in lupus nephritis","volume":"13","author":"Whittall-Garcia","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/bs.acc.2024.10.002_bib232","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211049963","article-title":"Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China","volume":"49","author":"Yang","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/bs.acc.2024.10.002_bib233","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-022-02763-4","article-title":"Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis","volume":"24","author":"Ding","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib234","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/09612033221145534","article-title":"Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus","volume":"32","author":"Faustini","year":"2023","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/bs.acc.2024.10.002_bib235","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.34426","article-title":"Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis","volume":"64","author":"Brunner","year":"2012","journal-title":"Arth.\u00a0Rheum."},{"issue":"2","key":"10.1016\/bs.acc.2024.10.002_bib236","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/art.41507","article-title":"Association between urinary epidermal growth factor and renal prognosis in lupus nephritis","volume":"73","author":"Mejia-Vilet","year":"2021","journal-title":"Arth.\u00a0Rheumatol."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524232400129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524232400129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:26:50Z","timestamp":1736861210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006524232400129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443343735"],"references-count":236,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2024.10.002","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}